AAAAAA
Results:
1-15
|
Results: 15
Authors:
Williams, SG
Gandour-Edwards, R
Deitch, AD
Toscano, S
Fan, JJ
Sternberg, CN
Pansadoro, V
Calabro, F
Rossetti, A
White, RWD
Citation: Sg. Williams et al., Differences in gene expression in muscle-invasive bladder cancer: A comparison of Italian and American patients, EUR UROL, 39(4), 2001, pp. 430-437
Authors:
Wijkstrom, H
Baker, WC
Deitch, AD
White, RWD
Citation: H. Wijkstrom et al., Urinary cytology and its role in diagnosis and monitoring of urothelial carcinoma, CURR CLIN U, 2001, pp. 103-132
Authors:
Kung, HJ
Tepper, CG
White, RWD
Citation: Hj. Kung et al., Tyrosine kinases and cellular signaling in prostate cancer, CONT CANC R, 2001, pp. 241-266
Authors:
Hall, WH
McGahan, JP
Link, DP
White, RWD
Citation: Wh. Hall et al., Combined embolization and percutaneous radiofrequency ablation of a solid renal tumor, AM J ROENTG, 174(6), 2000, pp. 1592-1594
Authors:
Chou, RH
Wilder, RB
Ji, M
Ryu, JK
Leigh, BR
Earle, JD
Doggett, RLS
Kubo, HD
Roach, M
White, RWD
Citation: Rh. Chou et al., Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy, INT J RAD O, 47(1), 2000, pp. 115-119
Authors:
White, RWD
Deitch, AD
Daneshmand, S
Blumenstein, B
Lowe, BA
Sagalowsky, AI
Smith, JA
Schellhammer, PF
Stanisic, TH
Grossman, HB
Messing, E
Crissman, JD
Crawford, ED
Citation: Rwd. White et al., The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer - A Southwest Oncology Group Study, EUR UROL, 37(5), 2000, pp. 595-600
Authors:
Dow, JK
White, RWD
Citation: Jk. Dow et Rwd. White, Fibroblast growth factor 2: Its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions, UROLOGY, 55(6), 2000, pp. 800-806
Authors:
Edelman, MJ
Meyers, FJ
Miller, TR
Williams, SG
Gandour-Edwards, R
White, RWD
Citation: Mj. Edelman et al., Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: A well-tolerated regimen with activity independent of p53 mutation, UROLOGY, 55(4), 2000, pp. 521-525
Authors:
White, RWD
Deitch, AD
Gumerlock, PH
Shi, XB
Citation: Rwd. White et al., Use of a yeast assay to detect functional alterations in p53 in prostate cancer: Review and future directions, PROSTATE, 41(2), 1999, pp. 134-142
Authors:
Hegarty, NJ
Fitzpatrick, JM
Richie, JP
Scardino, PT
White, RWD
Schroder, FH
Coffey, DS
Citation: Nj. Hegarty et al., Future prospects in prostate cancer, PROSTATE, 40(4), 1999, pp. 261-268
Authors:
Gumbiner, LM
Gumerlock, PH
Mack, PC
Chi, SG
White, RWD
Mohler, JL
Pretlow, TG
Tricoli, JV
Citation: Lm. Gumbiner et al., Overexpression of cyclin D1 is rare in human prostate carcinoma, PROSTATE, 38(1), 1999, pp. 40-45
Authors:
Huang, A
Fone, PD
Gandour-Edwards, R
White, RWD
Low, RK
Citation: A. Huang et al., Immunohistochemical analysis of bcl-2 protein expression in renal cell carcinoma, J UROL, 162(2), 1999, pp. 610-613
Authors:
Rademacher, DE
Gandour-Edwards, R
Toscano, S
Deitch, AD
Chiu, C
White, RWD
Citation: De. Rademacher et al., Loss of p53 and Bcl-2 immunopositivity with time on stored slides of prostate and bladder cancer, MOL UROL, 2(4), 1998, pp. 295-300
Authors:
White, RWD
Stapp, E
Citation: Rwd. White et E. Stapp, Predicting prognosis in patients with superficial bladder cancer, ONCOLOGY-NY, 12(12), 1998, pp. 1717-1723
Authors:
Meyers, FJ
Gumerlock, PH
Chi, SG
Borchers, H
Deitch, AD
White, RWD
Citation: Fj. Meyers et al., Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors, CANCER, 83(12), 1998, pp. 2534-2539
Risultati:
1-15
|